Hostname: page-component-54dcc4c588-m259h Total loading time: 0 Render date: 2025-09-30T07:52:48.693Z Has data issue: false hasContentIssue false

Accessory-pathway-mediated dilated cardiomyopathy in an infant

Published online by Cambridge University Press:  26 August 2025

Claire Bertail-Galoin*
Affiliation:
Felix Guyon Hospital Center, CHU La Réunion, Competence Center for Complex Congenital Heart Disease – M3C, Saint-Denis, France
Nabil Jbilou
Affiliation:
Felix Guyon Hospital Center, CHU La Réunion, Competence Center for Complex Congenital Heart Disease – M3C, Saint-Denis, France
Victor Waldmann
Affiliation:
Coordinating Center for Complex Congenital Heart Disease – M3C, Necker Enfants Malades Hospital, Paris, France
*
Corresponding author: Claire Bertail-Galoin; Email: claire.bertail@chu-reunion.fr

Abstract

We report the case of a 10-month-old infant presenting with dilated cardiomyopathy caused by septal dyssynchrony linked to a right septal accessory pathway-mediated pre-excitation. No atrioventricular reciprocating tachycardia was reported, but this pre-excitation resulted in left septal dyssynchrony. After the introduction of flecainide therapy, the antegrade pre-excitation disappeared on ECG, leading to normalisation of left ventricular function.

Information

Type
Case Report
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Udink, ten Cate FEA, Kruessell, MA, Wagner, K, et al. Dilated cardiomyopathy in children with ventricular preexcitation: the location of the accessory pathway is predictive of this association. J Electrocardiol 2010; 43: 146154.CrossRefGoogle Scholar
Miyazaki, A, Uemura, H. Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch. J Cardiol 2022; 79: 3035.CrossRefGoogle ScholarPubMed
Emmel, M, Balaji, S, Sreeram, N. Ventricular preexcitation associated with dilated cardiomyopathy: a causal relationship? Cardiol Young 2004; 14: 594599.CrossRefGoogle ScholarPubMed
Couchonnal, LF, Chicos, AB, Knight, BP. An unusual level of block in a patient with an unusual accessory pathway. Cardiovasc Electrophysiol 2012; 23: 334335.CrossRefGoogle Scholar
Zhang, Y, Jiang, H, Cui, J, Li, MT, Zhou, HM, Li, XM. Ablation of ventricular preexcitation to cure preexcitation-induced dilated cardiomyopathy in infants: diagnosis and outcome. Circ Arrhythm Electrophysiol 2023; 16: e011569.CrossRefGoogle ScholarPubMed
Sekine, M, Masutani, S, Imamura, T, et al. Improvement in dyssynchrony with pharmacological ablation of right-sided accessory pathway-induced cardiomyopathy in infants. Int Heart J 2019; 60: 12011205.CrossRefGoogle ScholarPubMed
Uthayakumaran, G, Asakai, H, Gnanappa, G. Pharmacological resynchronisation with flecainide in an infant with Ebstein anomaly and Wolff-Parkinson-White pattern: a case report. Eur Heart J Case Rep 2024; 8: ytae442.CrossRefGoogle Scholar
Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406412.CrossRefGoogle Scholar
Cunningham, T, Uzun, O, Morris, R, et al. The safety and effectiveness of flecainide in children in the current era. Pediatr Cardiol 2017; 38: 16331638.CrossRefGoogle ScholarPubMed
Kohli, V. Oral flecainide is effective in management of refractory tachycardia in infants. Indian Heart J 2013; 65: 168171.CrossRefGoogle ScholarPubMed